The Intercontinental Exchange (ICE), which owns and operates the New York Stock Exchange and more than a dozen markets and exchanges worldwide, officially announced its new cryptocurrency business last Friday. It’s called Bakkt, and the new platform will allow investors
August 11, 2018
Investors looking for blue-chip dividend stocks should consider the Dividend Aristocrats, which have increased their shareholder payouts for at least 25 years in a row. These stocks have stood the test of time, thanks to strong competitive advantages and top
Many observers have noted that the Chinese must eventually come to the US for some of their soybean needs, as the supply of Argentine and Brazilian soybeans are depleted and American soybeans are harvested. Current futures for November 2018 do
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. CHINA TARIFFS:
New Zealand Dollar Fundamental Forecast: Bearish NZD OUTLOOK TALKING POINTS: Dovish RBNZ and concerns over European bank exposure to Turkey sent NZD/USD lower Local economic event risk for the New Zealand Dollar sparse, placing focus on sentiment Brexit and lingering Turkish fears can weaken
Papa John’s International, Inc. announced a new assistance program for its franchisees in the United States and Canada. This program has the full support of the company’s Franchise Advisory Council and the Papa John’s Franchise Association, and follows conversations with
The latest index reading came in at 18.4, up from the previous week. RecessionAlert launched an alternative to ECRI’s Weekly Leading Index Growth indicator (WLIg). The Weekly Leading Economic Index (WLEI) uses fifty different time series from these categories: Corporate Bond Composite, Treasury
Shanghai Junshi Biosciences has filed for a Hong Kong IPO that is expected to raise up to $500 million (see story). Junshi is developing a pipeline of 13 biologic drugs, including immuno-oncology treatments. Its most advanced candidate, toripalimab, is a PD-1
Shanghai Junshi Biosciences has filed for a Hong Kong IPO that is expected to raise up to $500 million (see story). Junshi is developing a pipeline of 13 biologic drugs, including immuno-oncology treatments. Its most advanced candidate, toripalimab, is a PD-1
MON Sector Strength – TUE Rates – WED Medium-Term – THU Commodities Currencies – FRI Sentiment – SAT Longer-Term The Short-Term Trend The short-term trend is down as of Friday. The Junk Bond chart shows the break in trend clearly.
